"It takes a long time to get FDA approval [to put products onto the market], so the early part of the patent term is often used up in the approval process," says Raymond Mandra, a partner at Fitzpatrick, Cella, Harper & Scinto. "Then, when you bring the product onto the market, it will typically take time to build up market share. So at the end of the patent term, you generally are selling more of the product than you ever have. This is particularly true of blockbuster pharmaceuticals; their use continually grows through the years."
|Printer friendly Cite/link Email Feedback|
|Author:||Kappos, Wyeth V.|
|Date:||Apr 1, 2010|
|Previous Article:||Prolonging patent; Wyeth v. Kappos is a boon for companies wanting to extend their patent protection.|
|Next Article:||Second time around: business balks as the EPA revisits tighter limits on smog-causing pollutants.|